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Abstract
This study was undertaken to begin to elucidate the mechanisms by which cytokines influence intracellular iron
homeostasis. Intracellular iron homeostasis is maintained by the coordinated regulation of ferritin and transferrin receptor
synthesis. The synthesis of these proteins is coordinated by cytoplasmic iron regulatory proteins (IRP), which bind to iron
responsive elements (IRE) on their mRNAs. We evaluated the effects of interleukin-1L (IL-1L) on iron metabolism in human
astrocytoma cells (SW1088). Exposure to IL-1L for 16 h increased binding of the IRPs to the IRE and also increased ferritin
synthesis. Using the iron sensitive dye calcein, we determined that the intracellular labile iron pool increased within 4 h of
IL-1L exposure and continued to increase for 8 h, returning to normal by 16 h. We propose that the cytokine induced increase
in the labile iron pool stimulates ferritin synthesis resulting in a subsequent decrease in the labile iron pool. The decrease in
the labile iron pool is consistent with the increase in IRE/IRP interaction measured at 16 h. These results indicate that
cytokines can influence the labile iron pool and the post-transcriptional regulatory mechanism for maintaining iron
homeostasis. These results contribute to understanding the response of ferritin to inflammation by suggesting ferritin
synthesis may reflect changes in the labile iron pool. The approach used in this study may provide a model system for
studying relations between the labile iron pool and proteins responsible for maintaining intracellular homeostasis ß 2000
Elsevier Science B.V. All rights reserved.
Keywords: Iron regulation; Post-transcriptional regulation; mRNA; Cytokine; Fluorometry
1. Introduction
Maintenance of intracellular iron homeostasis is
critical to cell survival. A su⁄cient and timely supply
of iron must be available to cells to meet oxidative
requirements and support enzymatic activity. The
cytoplasmic fraction of iron, which contains the cells’
metabolically and catalytically reactive iron, is de-
¢ned as the labile iron pool (LIP) [1]. Maintenance
of the LIP, and intracellular iron homeostasis, is
achieved through the coordinated expression of
transferrin receptors for iron uptake and ferritin for
intracellular iron storage. Two cytoplasmic proteins,
known as iron regulatory protein 1 and 2 (IRP1 and
IRP2), recognize and bind to highly conserved RNA
structures identi¢ed as iron responsive elements
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(IREs) [2], regulating the synthesis of both transfer-
rin receptor (TfR) and ferritin at the post-transcrip-
tional level. Ferritin mRNA contains a single IRE in
the 5P untranslated region (UTR) [3], whereas TfR
mRNA contains ¢ve IREs in the 3P UTR. In addi-
tion, IREs have been reported in the 5P UTRs of
erythroid 5-aminolevulinic acid synthase [4,5] and
mitochondrial aconitase [5] mRNAs, implicating
the IRPs in regulation of erythroid protoporphyrin
biosynthesis and the citric acid cycle. In states of low
intracellular iron, IRPs bind to the IRE in the
5P UTR of ferritin or eALAS mRNA and inhibit
the translation of those mRNAs [5,6] by preventing
the binding of the 43S pre-initiation complex to
mRNA [7]. In contrast, IRP binding to IREs in the
3P UTR of TfR mRNA protects a speci¢c RNase
cleavage site and stabilizes the mRNA [8,9]. When
intracellular iron is high, the IRPs dissociate from
the mRNAs allowing the translation of ferritin
mRNA and the degradation of TfR mRNA. Thus,
the interaction between IRPs and IREs plays a cen-
tral role in the regulation of cellular iron homeosta-
sis.
Other factors can also a¡ect iron homeostasis.
There is considerable evidence that cytokines in£u-
ence intracellular iron [10^16]. These cytokines in-
clude interleukin-1K (IL-1K), interleukin-1L (IL-1L),
interleukin-2 (IL-2), and interleukin-6 (IL-6), as well
as tumor necrosis factor K and interferon Q. Cyto-
kines can modulate transferrin receptor and ferritin
expression by both transcriptional [11,13,17] and
translational mechanisms [14,15,18]. The e¡ects of
IL-1L, a major cytokine involved in acute in£amma-
tory responses, on TfR vary according to cell type
[12,13,16]. IL-1L also increases the hepatic transla-
tion of H and L ferritin subunits [19]. The e¡ect of
IL-1L on ferritin synthesis is reportedly post-tran-
scriptional [18].
As a key factor in post-transcriptional regulation
of ferritin and TfR, the e¡ect of cytokines on IRPs
has not been well addressed. There is, however, evi-
dence that cytokines may a¡ect the function of IRP.
For example, IL-2 induces accumulation of TfR
mRNA as the result of IRP activation [16,20]. In
addition, in human hepatoma cells, the induction
of L ferritin translation by IL-1L can be blocked
by iron chelators, suggesting that translational induc-
tion by IL-1L must occur after dissociation of IRP
from the IRE [18,20]. The purpose of this study is to
directly examine the e¡ect of IL-1L on IRE/IRP in-
teraction, ferritin synthesis, and the LIP.
2. Materials and methods
2.1. Cell culture
Human astrocytoma cells (SW1088) were pur-
chased from American Type Culture Collection
(Rockville, MD). The cells were grown at 37‡C in
a 5% CO2 atmosphere in Dulbecco’s modi¢ed
Eagle’s medium (Gibco, Rockville, MD) supple-
mented with 10% fetal bovine serum (Biocell, Ran-
cho Dominguez, CA). The cells were plated at 70%
con£uence and the studies were performed 24 h later.
The cells were exposed to IL-1L (1 or 10 ng/ml, Sig-
ma, St. Louis, MO) for 16 h. The concentration of
IL-1L and the exposure time were chosen based on
previous reports, which have shown IL-1L in£uences
ferritin synthesis [9]. To compare the response to
IL-1L to that seen for changes in iron levels, the cells
were exposed to either ferric ammonium citrate
(FAC, 100 Wg/ml, Sigma) or the iron chelator defer-
oxamine (DFO, 100 WM, Sigma) for 16 h.
To determine whether nitric oxide (NO) was in-
volved in the cytokine IRE/IRP response, cells were
exposed to 1 mM of the NO inhibitor nitro-L-argi-
nine methyl ester (L-NAME, Calbiochem, La Jolla,
CA) for 16 h.
2.2. RNA band shift assay
The pGEM 7Zf(+)-5PL containing the complete
5P UTR of rat liver L-ferritin cDNA was provided
by R.S. Eisenstein (University of Wisconsin-Madi-
son, WI). The RNA transcripts were synthesized
from 1 Wg linearized plasmid DNA in the presence
of 50 WCi [K-32P]CTP (800 Ci/mmol, DuPont, Wil-
mington, DE). The yield of transcript synthesized
was determined by trichloroacetic acid (TCA) precip-
itation. Unincorporated nucleotides were removed
with a G-50 Micro Column (Pharmacia, Piscataway,
NJ).
Binding reactions were carried out as described
previously [21]. Brie£y, the cytoplasmic extract was
incubated with radiolabeled RNA transcripts, which
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contained the IRE sequence. RNA^protein com-
plexes were separated on a 6% native polyacrylamide
gel and visualized by autoradiography. Antiserum to
IRP2 [22] was used in the band supershift assay.
2.3. Western blot analysis
Cells were homogenized in 10 mM HEPES pH 7.6,
3 mM MgCl2, 40 mM KCl, 5% glycerol, 1 mM di-
thiothreitol and 0.2% Nonidet P-40 supplemented
with 1 mM phenylmethylsulfonyl £uoride and 5 Wg/
ml of leupeptin (Sigma). A crude cytoplasmic extract
was obtained by centrifugation of homogenate at
10 000Ug for 30 min. The total protein concentra-
tion was determined using the Bio-Rad protein as-
say.
Equal amounts of cytoplasmic proteins were sepa-
rated on a 7.5% SDS^PAGE. After transfer to a
nitrocellulose membrane (Schleicher and Schuell,
Keene, NH) using the MilliBlot-SDE system (Milli-
pore, Bedford, MA), the membrane was blocked and
incubated overnight at 4‡C with either IRP1 antise-
rum (against peptide aa 408^421), which was pro-
vided by T.A. Rouault (National Institutes of
Health, Bethesda, MD), or IRP2 antiserum [22] pro-
vided by E.A. Leibold (University of Utah, Salt Lake
City, UT). Peroxidase conjugated goat anti-rabbit
IgG (Bio-Rad, Hercules, CA) was used as the sec-
ondary antibody. The ECL system was applied to
visualize the results.
2.4. Metabolic labeling and immunoprecipitation
After 16 h exposure to IL-1L (0, 1, or 10 ng/ml),
FAC (100 Wg/ml) or DFO (100 WM), the cells were
metabolically labeled with [35S]methionine for 1 h.
Equal amounts of TCA precipitable cytoplasmic ex-
tracts from human astrocytoma cells (SW1088) were
immunoprecipitated with anti-ferritin polyclonal
antibody (Boehringer Mannheim, Indianapolis, IN)
at 1:1000 dilution and separated on an 8% SDS^
PAGE. The intensity of each band was quantitated
by computerized densitometry.
2.5. Northern blot analysis
Total RNA was isolated by the methods described
by Chomczynski and Sacchi [23]. Equal amounts of
total RNA were separated on a 1% agarose gel and
transferred overnight to a nylon hybridization mem-
brane (Amersham, Piscataway, NJ) by capillary elu-
tion. After RNA was immobilized by UV crosslink-
ing, the membrane was placed between two 586 ¢lter
papers (Schleicher and Schuell) saturated in hybridi-
zation solution containing 5USSC, 50% formamide,
0.5% SDS and 2UDenhardt’s reagent. The cDNA
fragments derived from recombinant IRP1 or IRP2
cDNA clones (provided by T.A. Rouault, National
Institutes of Health) were labeled with [K-32P]dCTP
(DuPont) using a Random Primed DNA labeling kit
from Boehringer Mannheim. The radiolabeled
cDNA probe was added to the hybridization bu¡er
and incubated overnight at 42‡C. After sequential
washing, the membranes were exposed to X-ray
¢lm at 370‡C.
2.6. Measurement of cytoplasmic aconitase activity
Cytoplasmic aconitase activity was determined by
measuring the disappearance of cis-aconitate at
240 nm. Equal amounts of cytoplasmic protein ex-
tracts were incubated with 0.2 mM cis-aconitate in
the cuvette of a Beckman U64 spectrophotometer.
The speci¢c activity is expressed as U/100 Wg protein.
One unit of aconitase is de¢ned as that amount
which catalyzes the production of 1 Wmol of aconi-
tate per minute. The extinction coe⁄cient of cis-aco-
nitate was 3.41 mM31 cm31.
2.7. LIP experiment
The iron sensitive £uorescent dye calcein (Molec-
ular Probes, Eugene, OR) was used to evaluate the
e¡ects of IL-1L on the LIP of SW1088 cells in vivo.
Calcein acetoxymethyl ester (calcein-AM) is a £uo-
rescent dye that can be used as a cell viability marker
and as an intracellular iron marker [24^28]. Calcein-
AM is an EDTA analog that passively di¡uses across
the cell membrane. Once inside the cell, the acetoxy-
methyl ester is cleaved and calcein becomes £uores-
cent. The resulting de-esteri¢ed calcein is sequestered
in the cytosol [29^31]. Calcein is excited at 486 nm
and emits a green £uorescence at 517 nm. Inside the
cell, the calcein is stoichiometrically chelated by
Fe2;3 1:1, but not signi¢cantly by other metals at
physiologic pH. The interaction between the iron and
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the calcein is reversible [32]. When iron levels in-
crease in the LIP, the £uorescence is quenched, and
when the LIP levels are low, the £uorescence in-
creases, as shown under di¡erent experimental con-
ditions [1,33,34].
Human astrocytoma cells were plated at a density
of 6.0U104 cells/cm2 on 24-well plates. After 48 h the
cells were exposed to IL-1L containing medium
(10 ng/ml) for 4, 8, 12, or 16 h. Separate sets of cells
were exposed to either ferrous ammonium sulfate
(FAS, 100 WM) or DFO (100 WM) for 16 h. This
latter experiment allowed us to compare the e¡ects
of IL-1L on the LIP to those seen with changes in
iron availability. A control group (standard medium
only) was included with each treatment. At the end
of the treatment period, 0.25 WM calcein-AM was
added to the medium of both the experimental and
control cells for 20 min at 37‡ C. After 20 min, the
cells were washed twice with standard media to re-
move excess calcein. Fluorescent intensity was deter-
mined by taking 10 random measurements (20 ms
Fig. 1. E¡ect of IL-1L on the binding activity of IRPs in astro-
cytoma cells. Equal amounts of cytoplasmic protein extracts
(2 Wg) from astrocytoma cells were exposed to various concen-
trations of IL-1L (0, 1, and 10 ng/ml), FAC (100 Wg/ml) or
DFO (100 WM) for 16 h. Cytosolic extracts were incubated
with a radiolabeled ferritin mRNA IRE probe followed by
treatment with heparin and RNase T1. The RNA^protein com-
plexes were separated on a 6% native polyacrylamide gel and
then excised and quanti¢ed by liquid scintillation counting. The
results of a representative band shift assay are shown, as well
as a graph of the binding activity for the di¡erent treatments
expressed as percent of the untreated group. Values are means
and S.E.M. of six di¡erent experiments. All groups di¡ered sta-
tistically from the untreated control (P6 0.05).
Fig. 2. IRP supershift assay. To determine which of the IRPs
were responsible for the increase in IRP binding activity, a
supershift assay was performed. The analysis was performed in
triplicate and the results are shown in the graph as mean þ
S.E.M. The data are presented as percent of the untreated con-
dition so the total IRP is not the sum of IRP1 and IRP2. A
representative gel is shown to view the supershift. Antiserum to
IRP2 (provided by E.A. Leibold) was incubated with equal
amounts of protein extracts (2 Wg) from astrocytoma cells ex-
posed to IL-1L (10 ng/ml) for 16 h. After incubation, a radiola-
beled ferritin mRNA IRE probe was added to the antibody^ex-
tract mixture followed by treatment with RNase T1 and
heparin. The RNA^protein complexes were separated on a 6%
native polyacrylamide gel. The supershift analysis indicates that
the majority of the IRP binding as a result of IL-1L exposure
is IRP2, but IRP1 has the greater increase in binding activity
subsequent to IL-1L exposure. The asterisks indicate statistical
di¡erence from the respective untreated control (P6 0.05).
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each) of each well plate using a £uorometer (CpL
Instruments, Inc., Hummelstown, PA). Analysis of
variance was performed to compare the means be-
tween groups, followed by a Duncan’s new multiple-
range test.
3. Results
Human astrocytoma cells (SW1088) were exposed
to IL-1L (1^10 ng/ml) for 16 h. The binding activity
of cytoplasmic IRPs was determined using RNA
band shift assays. A single protein^RNA complex
was obtained in astrocytoma cell extracts (Fig. 1).
IL-1L treatment induced an increase in the binding
activity of IRPs in astrocytoma cells. It appears that
only a portion of IRPs respond to the IL-1L treat-
ment, since increasing the concentration of IL-1L
from 1 to 10 ng/ml had no additional e¡ect on the
binding activity, and the e¡ect of 10 ng/ml IL-1L on
the binding activity was 25% less than that of the
iron chelator DFO at 100 WM for the same period
treatment.
Two IRPs have been identi¢ed in human and oth-
er species, and the human IRP1/IRE and IRP2/IRE
complexes co-migrate on band shift assay [20]. To
distinguish the possibility of a di¡erential e¡ect of
IL-1L on IRP1 and IRP2, an RNA band supershift
assay was performed. The titration of antibody re-
quired to separate IRP2/IRE complex from IRP1/
IRE complex was determined empirically to be 5 Wl.
Addition of IRP2 antiserum resulted in the appear-
ance of a high molecular weight IRP2 complex (Fig.
2). The density of the IRP2 complexes is not di¡erent
in the presence or absence of IL-1L, whereas the
remaining IRP1 complex is clearly more intense in
the IL-1L treated cells than in the absence of IL-1L.
These results demonstrated that the e¡ect of IL-1L is
primarily on IRP1 and that it has little or no e¡ect
on IRP2.
To di¡erentiate between transcriptional regulation
and post-transcriptional regulation of IRP1 in re-
sponse to IL-1L, Western blot assays were performed
to compare the total amount of IRP1 and IRP2 in
control and IL-1L treated cells. The intensity of the
bands corresponding to IRP1 and IRP2 was not af-
fected by IL-1L treatment (Fig. 3). This suggests that
there is not an increase in total IRP1 or IRP2 and
that the e¡ect of IL-1L on IRP1 occurs at post-trans-
lational level.
IRP1 is a dual function protein with IRE binding
Fig. 3. E¡ect of IL-1L on the expression of IRPs. To determine
if total IRP was increased as a result of IL-1L exposure a West-
ern blot analysis was performed. Equal amounts of protein ex-
tracts (30 Wg) were separated on an 8% SDS^PAGE and trans-
ferred to nitrocellulose membranes. The membranes were
immunoblotted with antisera to either IRP1 or IRP2. The re-
sults were visualized by incubating the membranes with ECL
substrates. The blot shown is representative of three experi-
ments and shows that there is no increase in total IRP1 or
IRP2 with IL-1L exposure.
Fig. 4. E¡ect of IL-1L on cytoplasmic aconitase activity. Repre-
sentative plot of the determination of cytoplasmic aconitase ac-
tivity. Cytoplasmic aconitase activity was determined by mea-
suring the disappearance of cis-aconitate at 240 nm. Equal
amounts of cytoplasmic protein extracts (100 Wg) from astrocy-
toma cells previously exposed to IL-1L (0 or 10 ng/ml) were in-
cubated with 0.2 mM cis-aconitate in 50 mM Tris (pH 7.2),
100 mM NaCl, 0.02% BSA at room temperature in the cuvette
of a Beckman U64 spectrophotometer. These results show that
in a 10-minute period there is less aconitase activity in IL-1L
treated samples than in the untreated (control) samples (statisti-
cally signi¢cant at P6 0.05). The analysis of cytoplasmic aconi-
tase activity was repeated three di¡erent times on three di¡erent
sets of cells and the results were the same each time.
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activity and aconitase activity. The two functions are
mutually exclusive and are reciprocally regulated by
changes in the iron^sulfur cluster of the protein. Be-
cause IRP1 binding activity was enhanced by IL-1L,
but the total IRP1 protein was not a¡ected, we pre-
dicted that cytoplasmic aconitase would be dimin-
ished by IL-1L treatment. The results of this experi-
ment are shown in Fig. 4. Treatment with IL-1L
resulted in a decrease in cytoplasmic aconitase activ-
ity. These data indicate that cytoplasmic aconitase
activity is inhibited by IL-1L in human astrocytoma
cells, consistent with the increase in IRP1 binding
activity. The results suggest that the IL-1L e¡ect on
IRP1 is at the post-translational level.
IL-1 has been shown to induce the production of
intracellular NO, and NO promotes IRP binding ac-
tivity [35^38]. Consequently, we investigated whether
the increase in IRP1 binding by IL-1L is through a
NO pathway. The addition of the NO inhibitor
L-NAME (Fig. 5A) did not a¡ect the ability of
IL-1L to promote IRP binding activity. However,
the e¡ect of IL-1L on IRP1 can be blocked in the
presence of iron excess (Fig. 5B). These data suggest
that the activation of IRP1 by IL-1L is independent
Fig. 5. E¡ect of L-NAME and iron availability on the IRPs. Equal amounts of cytoplasmic protein extracts (2 Wg) from astrocytoma
cells exposed to IL-1L (0, 10 ng/ml), L-NAME (1 mM) or FAC (100 Wg/ml) for 16 h. The extracts were incubated with a radiolabeled
ferritin mRNA IRE probe, followed by treatment with heparin and RNase T1. The RNA^protein complexes were separated on a 6%
native polyacrylamide gel. (A) The results of the L-NAME exposure studies indicate that NO does not mediate the IRE/IRP binding
activity. The asterisks indicate statistical di¡erence from the untreated group (P6 0.05). (B) Iron treatment decreases the IRE/IRP
binding activity both in the presence and in the absence of IL-1L. All groups are statistically di¡erent from the control group
(P6 0.05). The gel shift assays in this ¢gure are representative of three separate experiments. The graphs represent the means þ S.E.M.
of the three experiments.
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of NO production but is a¡ected by the iron status
of the cell.
To investigate the e¡ects of the alteration of IRP1
function by IL-1L on indicators of cellular iron ho-
meostasis, the synthesis of ferritin was determined by
Western blot assay. The synthesis of both H and L
subunits of ferritin was increased by IL-1L. The in-
crease in ferritin synthesis in response to IL-1L treat-
ment was less than that seen in response to iron
treatment. Exposure to DFO decreased ferritin syn-
thesis (Fig. 6). To determine the site at which IL-1L
a¡ects ferritin and TfR mRNA synthesis, the
amounts of L ferritin and TfR mRNAs were deter-
mined by Northern blot assay using L-actin mRNA
as control. As shown in Fig. 7, IL-1L had no e¡ect
on either TfR mRNA or L ferritin mRNA, indicat-
ing that IL-1L does not increase ferritin mRNA tran-
scription, which is consistent with existing reports
[6,18] that the IL-1L induced increase in ferritin is
due to post-transcriptional mechanisms.
The e¡ects of IL-1L on the LIP were investigated
by £uorometric measurement of the changes in cal-
cein £uorescence at di¡erent treatment times. After
treatment with IL-1L, there was a time dependent
decrease in calcein £uorescence up to 8 h, followed
by an increase in £uorescence that were similar to
control levels by 16 h (Fig. 8). Since the £uorescence
of calcein is inversely proportional to the size of the
LIP, these changes indicate an increase in the LIP at
4 and 8 h, followed by a decrease at 12 and 16 h. At
8 h, the LIP of the IL-1L treated group, as measured
by the calcein £uorescence, was not statistically dif-
ferent from the iron loaded group. Treatment of the
cells with the iron chelator DFO produced an in-
crease in £uorescence relative to the control group,
while iron supplementation resulted in a decrease in
£uorescence (Fig. 8).
Fig. 6. E¡ect of IL-1L on synthesis of ferritin. Human astrocy-
toma cells (SW1088) were cultured in DMEM plus 10% fetal
bovine serum. After 16 h exposure to IL-1L (1 or 10 ng/ml),
FAC (100 Wg/ml), or DFO (100 WM), cells were metabolically
labeled with [35S]methionine for 1 h. Equal amounts of TCA
precipitable cytoplasmic extracts were immunoprecipitated with
anti-ferritin polyclonal antibody and separated on an 8% SDS^
PAGE. The results in the representative Western blot show that
ferritin synthesis is increased by IL-1L exposure and iron, and
is decreased by iron chelation with DFO. The untreated group
(U, standard medium conditions) served as control. The e¡ect
of IL-1L on ferritin synthesis was repeated in three experiments
and the results are shown in the graph as percent of the un-
treated group (mean þ S.E.M.). The synthesis of both H and L
ferritin increased signi¢cantly by IL-1L exposure (P6 0.05). The
e¡ects of exposure to iron (FAC) and iron chelation (DFO) are
shown on the Western blot for comparison.
Fig. 7. E¡ect of IL-1L on mRNA of TfR and ferritin. The ef-
fect of IL-1L on the expression of ferritin or TfR mRNA was
determined using Northern blot analysis. The blot shown here
is a representative of three separate experiments. Total RNA
(20 Wg) was separated on a 1% agarose gel and transferred to a
nylon membrane. The membranes were hybridized to antisense
RNA probes derived from cDNA clones encoding human ferri-
tin L subunit, TfR, or L-actin. These results demonstrate that
IL-1L exposure had no e¡ect on the expression of either TfR
mRNA or ferritin mRNA (U = untreated cells). Exposure to
FAC (100 Wg/ml), or DFO (100 WM) had the predicted e¡ect
on mRNA expression. None of the treatments a¡ected L-actin
mRNA expression.
BBAMCR 14652 11-9-00
D.J. Pin‹ero et al. / Biochimica et Biophysica Acta 1497 (2000) 279^288 285
4. Discussion
The results of this study demonstrate that IL-1L
increases IRP binding to IRE, but does not increase
total IRP. The IL-1L induced binding activity does
not involve the total amount of IRP available, be-
cause the response to the highest concentration of
IL-1L is less than that seen with iron chelation. Fur-
thermore, based on supershift analysis, IRP1 re-
sponds much more robustly to IL-1L exposure than
IRP2. This latter observation is consistent with the
decrease in cytoplasmic aconitase activity seen sub-
sequent to IL-1L exposure. The data also indicate
that the cytokine e¡ect is directly on the IRP, and
not mediated by the ability of cytokines to in£uence
NO [39^42], or the ability of NO to in£uence IRE/
IRP interaction [35^38,43]. However, the cytokine
e¡ect can be modi¢ed by cellular iron status as
shown when the cells were iron loaded prior to the
treatment with IL-1L. We have also shown that IL-
1L increases the intracellular LIP. The observed ef-
fect of IL-1L on the IRE/IRP interaction and ferritin
synthesis may be explained by the changes observed
over the 16 h time period in the LIP.
The present results also reveal that IL-1L stimu-
lates synthesis of H and L ferritin subunits at the
post-transcriptional level. These results are consistent
with other reports [14,17,19] but are not consistent
with the current theory that stimulation of IRP bind-
ing should inhibit ferritin synthesis. Thus, our results
could indicate that IRE/IRP interaction is not the
sole regulator of post-transcriptional regulation of
ferritin synthesis in the presence of IL-1L, and sup-
port the argument for an IL-1 responsive element on
the 5P UTR of ferritin mRNA [18,44]. In addition, it
has been suggested that IL-1 can directly a¡ect the
translational e⁄ciency of ferritin mRNA [18]. Thus,
our observation of increased IRE/IRP interaction
following IL-1L exposure could re£ect a decreasing
intracellular iron pool as a result of increased ferritin
Fig. 8. Measurements of the intracellular LIP. Human astrocytoma cells (SW1088) were incubated with IL-1L for 4, 8, 12 or 16 h.
The iron sensitive dye calcein was added for 20 min to examine the LIP. DFO (100 WM) and FAS (100 WM) were used to show the
e¡ects of iron chelation and iron loading, respectively, on calcein £uorescence activity. Following exposure to IL-1L, a decrease in
£uorescence activity (indicating an increase in the LIP) was observed at 4 h, and reached nadir at 8 h. The £uorescence activity of cal-
cein at 12 h was greater than at 8 h, and reached a level identical to control by 16 h. Because binding to iron quenches the calcein
£uorescence activity, these results indicate that IL-1L produced an initial increase in the LIP followed by a decrease to normal levels
by 16 h. The £uorescence activity of control wells containing cells in standard medium was read with each experimental group When
compared to the untreated control group, the £uorescence activity was higher for the iron chelation group (DFO) and lower for the
iron-supplemented group (FAS). Di¡erent letters indicate statistical di¡erences (P6 0.001).
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synthesis. This interpretation is consistent with the
decrease in LIP after 8 h of IL-1L exposure as deter-
mined using the iron sensitive dye calcein. We did
not observe changes in TfR mRNA with IL-1L ex-
posure suggesting there is not an increase in cellular
iron uptake. This interpretation is consistent with
previous reports that cytokines induce ferritin syn-
thesis without increasing cellular iron uptake [19].
Thus we consider that the initial increase in the
LIP came from release of intracellular stored iron
perhaps from ferritin or from mitochondria.
In conclusion, these results indicate that the appar-
ently con£icting e¡ect of IL-1L on promoting the
interaction between IRE and IRP, while increasing
ferritin synthesis, may be explained by changes in the
intracellular LIP. The initial cytokine induced in-
crease in the LIP may occur as a response to the
metabolic and biosynthetic demands placed upon a
cell in response to cytokine stimulation. Subse-
quently, intracellular ferritin concentration may be
increased, diminishing the LIP size. Iron loading
for 16 h increased the LIP to the same level as
seen after 8 h of IL-1L exposure yet the cytokine
e¡ect on IRE/IRP was negated by iron loading.
This suggests that the LIP had already reached a
concentration that inhibited IRE/IRP interaction
and increased ferritin synthesis blunting any addi-
tional ferritin synthesis or IRE/IRP response. This
interpretation suggests that the cytokine induced
IRE/IRP response is secondary to the changes in
the LIP and not a direct e¡ect on the IRE/IRP in-
teraction. The data do not rule out that ferritin syn-
thesis can be directly induced by cytokines.
Our study is among the ¢rst to study the relation-
ship between IRE/IRP interaction, ferritin synthesis
and the LIP in neural cells. The extent to which these
data can be generalized to non-CNS cells remains to
be seen, but it should be consistent with other tumor
cell lines. Thus, this system could provide a model
for studying the intracellular response of iron and
ferritin to in£ammation.
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